138 related articles for article (PubMed ID: 17932809)
41. Gene therapy progress and prospects cancer: oncolytic viruses.
Liu TC; Kirn D
Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
[TBL] [Abstract][Full Text] [Related]
42. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.
Liu TC; Galanis E; Kirn D
Nat Clin Pract Oncol; 2007 Feb; 4(2):101-17. PubMed ID: 17259931
[TBL] [Abstract][Full Text] [Related]
43. MicroRNAs fine-tune oncolytic viruses.
Bell JC; Kirn D
Nat Biotechnol; 2008 Dec; 26(12):1346-8. PubMed ID: 19060871
[No Abstract] [Full Text] [Related]
44. Technology evaluation: NV-1020, MediGene.
Reinis M
Curr Opin Mol Ther; 2005 Aug; 7(4):366-75. PubMed ID: 16121703
[TBL] [Abstract][Full Text] [Related]
45. HSV-1-derived recombinant and amplicon vectors for preventive or therapeutic gene transfer: an overview.
Epstein AL
Gene Ther; 2005 Oct; 12 Suppl 1():S153. PubMed ID: 16231048
[No Abstract] [Full Text] [Related]
46. Engineering adenovirus genome by bacterial artificial chromosome (BAC) technology.
Ruzsics Z; Lemnitzer F; Thirion C
Methods Mol Biol; 2014; 1089():143-58. PubMed ID: 24132484
[TBL] [Abstract][Full Text] [Related]
47. Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNA.
Saeki Y; Breakefield XO; Chiocca EA
Methods Mol Med; 2003; 76():51-60. PubMed ID: 12526158
[No Abstract] [Full Text] [Related]
48. Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic herpes Simplex type 1 (oHSV) for Generation and Isolation of HSV-Based Vectors.
Abdoli Sh; Roohvand F; Teimoori-Toolabi L; Shokrgozar MA; Bahrololoumi M; Azadmanesh K
Iran Biomed J; 2017 Jul; 21(4):206-17. PubMed ID: 28525954
[TBL] [Abstract][Full Text] [Related]
49. HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses.
Menotti L; Avitabile E; Gatta V; Malatesta P; Petrovic B; Campadelli-Fiume G
Viruses; 2018 Jun; 10(7):. PubMed ID: 29966356
[TBL] [Abstract][Full Text] [Related]
50. Exploiting synergies between radiation and oncolytic viruses.
Harrington KJ; Melcher A; Vassaux G; Pandha HS; Vile RG
Curr Opin Mol Ther; 2008 Aug; 10(4):362-70. PubMed ID: 18683101
[TBL] [Abstract][Full Text] [Related]
51. Considerations for intravascular administration of oncolytic herpes virus for the treatment of multiple liver metastases.
Nomura N; Kasuya H; Watanabe I; Shikano T; Shirota T; Misawa M; Sugimoto H; Kanazumi N; Nomoto S; Takeda S; Nakao A
Cancer Chemother Pharmacol; 2009 Jan; 63(2):321-30. PubMed ID: 18575868
[TBL] [Abstract][Full Text] [Related]
52. Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes.
Pühler F; Willuda J; Puhlmann J; Mumberg D; Römer-Oberdörfer A; Beier R
Gene Ther; 2008 Mar; 15(5):371-83. PubMed ID: 18200068
[TBL] [Abstract][Full Text] [Related]
53. Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer.
Bailer SM; Funk C; Riedl A; Ruzsics Z
Virus Genes; 2017 Oct; 53(5):741-748. PubMed ID: 28634751
[TBL] [Abstract][Full Text] [Related]
54. Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens.
Cui HY; Wang YF; Shi XM; An TQ; Tong GZ; Lan DS; He L; Liu CJ; Wang M
J Virol Methods; 2009 Mar; 156(1-2):66-72. PubMed ID: 19026690
[TBL] [Abstract][Full Text] [Related]
55. oHSV Genome Editing by Means of galK Recombineering.
Menotti L; Leoni V; Gatta V; Petrovic B; Vannini A; Pepe S; Gianni T; Campadelli-Fiume G
Methods Mol Biol; 2020; 2060():131-151. PubMed ID: 31617176
[TBL] [Abstract][Full Text] [Related]
56. Antitumor activity of a selectively replication competent herpes simplex virus (HSV) with enzyme prodrug therapy.
Braidwood L; Dunn PD; Hardy S; Evans TR; Brown SM
Anticancer Res; 2009 Jun; 29(6):2159-66. PubMed ID: 19528476
[TBL] [Abstract][Full Text] [Related]
57. Oncolytic replicating virus therapy: is the time right?
Günzburg WH
Curr Opin Mol Ther; 2005 Aug; 7(4):291-2. PubMed ID: 16121693
[No Abstract] [Full Text] [Related]
58. [Construction of a recombinant BAC-HSV-1 strain HF with a GFP reporter gene and characterization of its infectious progeny virus].
Liu XJ; Song B; Lu JM; Wang QZ; Han ZQ; Xu YM
Bing Du Xue Bao; 2011 May; 27(3):238-43. PubMed ID: 21774249
[TBL] [Abstract][Full Text] [Related]
59. Bacterial artificial chromosome transgenesis for zebrafish.
Yang Z; Jiang H; Lin S
Methods Mol Biol; 2009; 546():103-16. PubMed ID: 19378100
[TBL] [Abstract][Full Text] [Related]
60. Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses.
Mück-Häusl M; Solanki M; Zhang W; Ruzsics Z; Ehrhardt A
Nucleic Acids Res; 2015 Apr; 43(8):e50. PubMed ID: 25609697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
